Implications of Hepatitis E Virus in Blood Transfusions, Hemodialysis, and Solid Organ Transplants
Abstract
:1. Introduction
2. General Epidemiology
3. Diagnosis of HEV
4. HEV in Blood Transfusion
4.1. Seroprevalence in Europe
4.2. Seroprevalence in Asia and Africa
4.3. Seroprevalence in America and Argentina
5. HEV among Hemodialysis Patients
6. HEV in Solid Organ Transplant Recipients
6.1. Kidney
6.2. Liver
6.3. Lung
6.4. Heart
7. Prevention
8. Conclusions
Author Contributions
Funding
Conflicts of Interest
Abbreviations
HAV | Hepatitis A Virus |
HBV | Hepatitis B Virus |
HCV | Hepatitis C Virus |
HDV | Hepatitis D Virus |
HEV | Hepatitis E Virus |
RNA | Ribonucleic acid |
FDA | Food and Drug Administration |
EIA | Enzyme Immunoassays |
RT-PCR | Reverse-transcription polymerase chain reaction |
WHO | World Health Organization |
IU/ML | International units/milliliter |
LAMP | Loop-mediated isothermal amplification |
ORF | Open reading frame |
IGM | Immunoglobulin M |
IGG | Immunoglobulin G |
ELISA | Enzyme-linked immunosorbent assay |
HIV | Human immunodeficiency Virus |
ALT | Alanine aminotransferase |
CHD | Chronic hemodialysis |
HD | Hemodialysis |
CD | Cluster of differentiation |
CSF | Cerebrospinal fluid |
References
- Saracco, G.M.; Evangelista, A.; Fagoonee, S.; Ciccone, G.; Bugianesi, E.; Caviglia, G.P.; Abate, M.L.; Rizzetto, M.; Pellicano, R.; Smedile, A. Etiology of chronic liver diseases in the Northwest of Italy, 1998 through 2014. World J. Gastroenterol. 2016, 22, 8187–8193. [Google Scholar] [CrossRef] [PubMed]
- Khaliq, S.; Raza, S.M. Current Status of Direct Acting Antiviral Agents against Hepatitis C Virus Infection in Pakistan. Medicina 2018, 54, 80. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Wong, D.C.; Purcell, R.H.; Sreenivasan, M.A.; Rama Prasad, S.; Pavri, K.M. Epidemic and Endemic Hepatitis in India: Evidence for a Non-A, Non-B hepatitis Virus Aetiology. Lancet 1980, 316, 876–879. [Google Scholar] [CrossRef]
- Balayan, M.S.; Andjaparidze, A.G.; Savin Skaya, S.S.; Ketiladze, E.S.; Braginsky, D.M.; Suvinov, A.P.; Poleschuk, V.F. Evidence for a Virus in Non-A, Non-B Hepatitis Transmitted via the Fecal-Oral Route. Intervirology 1983, 20, 23–31. [Google Scholar] [PubMed]
- Reyes, G.R.; Purdy, M.A.; Kim, J.P.; Luk, K.C.; Young, L.M.; Fry, K.E.; Bradley, D.W. Isolation of a cDNA from the virus responsible for enterically transmitted non-A, non-B hepatitis. Science 1990, 247, 1335–1339. [Google Scholar] [CrossRef] [PubMed]
- Kumar, S.; Subhadra, S.; Singh, B.; Panda, B.K. Hepatitis E Virus: The Current Scenario. Int. J. Infect. Dis. 2013, 17, e228–e233. [Google Scholar] [CrossRef] [Green Version]
- Kamar, N.; Bendall, R.; Legrand-Abravanel, F.; Xia, N.-S.; Ijaz, S.; Izopet, J.; Dalton, H.R. Hepatitis E Seminar. Lancet 2012, 6736, 1–12. [Google Scholar]
- Emerson, S.; Purcell, R. Hepatitis E Virus. In Fields Virology; Lippincot-Raven Publishers: Philadelphia, PA, USA, 2007; pp. 3048–3059. [Google Scholar]
- Takahashi, M.; Tanaka, T.; Takahashi, H.; Hoshino, Y.; Nagashima, S.; Jirintai, S.; Mizuo, H.; Yazaki, Y.; Takagi, T.; Azuma, M.; et al. Hepatitis E Virus (HEV) strains in serum samples can replicate efficiently in cultured cells despite the coexistence of HEV antibodies: Characterization of HEV virions in blood circulation. J. Clin. Microbiol. 2010, 48, 1112–1125. [Google Scholar] [CrossRef] [Green Version]
- Feng, Z.; Hirai-Yuki, A.; McKnight, K.L.; Lemon, S.M. Naked Viruses That Aren’t Always Naked: Quasi-Enveloped Agents of Acute Hepatitis. Annu. Rev. Virol. 2014, 1, 539–560. [Google Scholar] [CrossRef]
- Nagashima, S.; Takahashi, M.; Kobayashi, T.; Tanggis, N.; Nishizawa, T.; Nishiyama, T.; Primadharsini, P.P.; Okamoto, H. Characterization of the Quasi-Enveloped Hepatitis E Virus Particles Released by the Cellular Exosomal Pathway. J. Virol. 2017, 91, e00822-17. [Google Scholar] [CrossRef] [Green Version]
- Nan, Y.; Zhang, Y.J. Molecular Biology and Infection of Hepatitis E Virus. Front. Microbiol. 2016, 7. [Google Scholar] [CrossRef] [PubMed]
- Meng, X.J. Hepatitis E Virus: Animal Reservoirs and Zoonotic Risk. Vet. Microbiol. 2010, 140, 256–265. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Alam, S.; Azam, G.; Mustafa, G.; Azad, A.K.; Haque, I.; Gani, S.; Ahmad, N.; Alam, K.; Khan, M. Natural Course of Fulminant Hepatic Failure: The Scenario in Bangladesh and the Differences from the West. Saudi J. Gastroenterol. 2009, 15, 229–233. [Google Scholar] [CrossRef] [PubMed]
- Jilani, N.; Das, B.C.; Husain, S.A.; Baweja, U.K.; Chattopadhya, D.; Gupta, R.K.; Sardana, S.; Kar, P. Hepatitits E Virus Infection and Fulminant Hepatic Failure during Pregnancy. J. Gastroenterol. Hepatol. 2007, 22, 676–682. [Google Scholar] [CrossRef]
- Golkocheva-Markova, E.; Peleva-Pishmisheva, M.; Bruni, R.; Villano, U.; Pisani, G.; Equestre, M.; Kevorkyan, A.; Ciccozzi, M.; Ciccaglione, A. Following a patient with prolonged response against hepatitis E virus. Panminerva Medica 2018, 60, 232–234. [Google Scholar] [CrossRef]
- Kamar, N.; Selves, J.; Mansuy, J.M.; Ouezzani, L.; Péron, J.M.; Guitard, J.; Cointault, O.; Esposito, L.; Abravanel, F.; Danjoux, M.; et al. Hepatitis E Virus and Chronic Hepatitis in Organ-Transplant Recipients. N. Engl. J. Med. 2008, 358, 811–817. [Google Scholar] [CrossRef] [Green Version]
- Purcell, R.H.; Emerson, S.U. Hepatitis E: An Emerging Awareness of an Old Disease. J. Hepatol. 2008, 48, 494–503. [Google Scholar] [CrossRef]
- Teshale, E.H.; Hu, D.J.; Holmberg, S.D. The Two Faces of Hepatitis E Virus. Clin. Infect. Dis. 2010, 51, 328–334. [Google Scholar] [CrossRef]
- Kamar, N.; Dalton, H.R.; Abravanel, F.; Izopet, J. Hepatitis E Virus Infection. Clin. Microbiol. Rev. 2014, 27, 116–138. [Google Scholar] [CrossRef] [Green Version]
- Naik, S.R.; Aggarwal, R.; Salunke, P.N.; Mehrotra, N.N. A Large Waterborne Viral Hepatitis E Epidemic in Kanpur, India. Bull. World Health Organ. 1992, 70, 597–604. [Google Scholar]
- Lapa, D.; Capobianchi, M.R.; Garbuglia, A.R. Epidemiology of Hepatitis E Virus in European Countries. Int. J. Mol. Sci. 2015, 16, 25711–25743. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Geng, Y.; Zhao, C.; Fan, J.; Harrison, T.J.; Zhang, H.; Lian, H.; Geng, K.; Wang, Y. Genotype Analysis of Hepatitis e Virus from Sporadic Hepatitis e Cases in Northern China. Infect. Genet. Evol. 2013, 20, 413–417. [Google Scholar] [CrossRef] [PubMed]
- Vivek, R.; Nihal, L.; Illiayaraja, J.; Reddy, P.K.; Sarkar, R.; Eapen, C.E.; Kang, G. Investigation of an Epidemic of Hepatitis E in Nellore in South India. Trop. Med. Int. Health. 2010, 15, 1333–1339. [Google Scholar] [CrossRef] [PubMed]
- Khan, A.; Tanaka, Y.; Kurbanov, F.; Elkady, A.; Abbas, Z.; Azam, Z.; Subhan, A.; Raza, S.; Razza, S.; Hamid, S.; et al. Investigating an Outbreak of Acute Viral Hepatitis Caused by Hepatitis E Virus Variants in Karachi, South Pakistan. J. Med. Virol. 2011, 83, 622–629. [Google Scholar] [CrossRef]
- Garbuglia, A.R.; Scognamiglio, P.; Petrosillo, N.; Mastroianni, C.M.; Sordillo, P.; Gentile, D.; La Scala, P.; Girardi, E.; Capobianchi, M.R. Hepatitis E Virus Genotype 4 Outbreak, Italy, 2011. Emerg. Infect. Dis. 2013, 19, 110–114. [Google Scholar] [CrossRef] [Green Version]
- Pujhari, S.K.; Kumar, S.; Ratho, R.K.; Chawla, Y.K.; Chakraborti, A. Phylogenetic Analysis and Subtyping of Acute and Fulminant Strains of Hepatitis E Virus Isolates of North India with Reference to Disease Severity. Arch. Virol. 2010, 155, 1483–1486. [Google Scholar] [CrossRef]
- Kumar, S.; Pujhari, S.K.; Chawla, Y.K.; Chakraborti, A.; Ratho, R.K. Molecular Detection and Sequence Analysis of Hepatitis E Virus in Patients with Viral Hepatitis from North India. Diagn. Microbiol. Infect. Dis. 2011, 71, 110–117. [Google Scholar] [CrossRef]
- Majumdar, M.; Singh, M.P.; Pujhari, S.K.; Bhatia, D.; Chawla, Y.; Ratho, R.K. Hepatitis E Virus Antigen Detection as an Early Diagnostic Marker: Report from India. J. Med. Virol. 2013, 85, 823–827. [Google Scholar] [CrossRef]
- van Cuyck-Gandré, H.; Zhang, H.Y.; Tsarev, S.A.; Warren, R.L.; Caudill, J.D.; Snellings, N.J.; Bégot, L.; Innis, B.L.; Longer, C.F. Short Report: Phylogenetically Distinct Hepatitis E Viruses in Pakistan. Am. J. Trop. Med. Hyg. 2000, 62, 187–189. [Google Scholar] [CrossRef] [Green Version]
- Delarocque-Astagneau, E.; Abravanel, F.; Moshen, A.; Le Fouler, L.; Gad, R.R.; El-Daly, M.; Ibrahim, E.M.; El-Aidy, S.; Lashin, T.; El-Hoseiny, M.; et al. Epidemiological and Virological Characteristics of Symptomatic Acute Hepatitis E in Greater Cairo, Egypt. Clin. Microbiol. Infect. 2012, 18, 982–988. [Google Scholar] [CrossRef] [Green Version]
- Blackard, J.T.; Rouster, S.D.; Nady, S.; Galal, G.; Marzuuk, N.; Rafaat, M.M.; Daef, E.; El Din, S.S.; Purcell, R.H.; Emerson, S.U.; et al. Genotypic Characterization of Symptomatic Hepatitis E Virus (HEV) Infections in Egypt. J. Clin. Virol. 2009, 46, 140–144. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- García, C.G.; Sánchez, D.; Villalba, M.C.M.; Pujol, F.H.; de Los Ángeles Rodríguez Lay, L.; Pinto, B.; Chacón, E.P.; Guzmán, M.G. Molecular Characterization of Hepatitis E Virus in Patients with Acute Hepatitis in Venezuela. J. Med. Virol. 2012, 84, 1025–1029. [Google Scholar] [CrossRef] [PubMed]
- Harun-Or-Rashid, M.; Akbar, S.M.F.; Takahashi, K.; Al-Mahtab, M.; Khan, M.S.I.; Alim, M.A.; Ekram, A.R.M.S.; Khan, M.M.R.; Arai, M.; Mishiro, S. Epidemiological and Molecular Analyses of a Non-Seasonal Outbreak of Acute Icteric Hepatitis E in Bangladesh. J. Med. Virol. 2013, 85, 1369–1376. [Google Scholar] [CrossRef] [PubMed]
- Huang, C.C.; Nguyen, D.; Fernandez, J.; Yun, K.Y.; Fry, K.E.; Bradley, D.W.; Tam, A.W.; Reyes, G.R. Molecular Cloning and Sequencing of the Mexico Isolate of Hepatitis E Virus (HEV). Virology 1992, 191, 550–558. [Google Scholar] [CrossRef]
- Ijaz, S.; Arnold, E.; Banks, M.; Bendall, R.P.; Cramp, M.E.; Cunningham, R.; Dalton, H.R.; Harrison, T.J.; Hill, S.F.; Macfarlane, L.; et al. Non-Travel-Associated Hepatitis E in England and Wales: Demographic, Clinical, and Molecular Epidemiological Characteristics. J. Infect. Dis. 2005, 192, 1166–1172. [Google Scholar] [CrossRef]
- Hakze-van der Honing, R.W.; van Coillie, E.; Antonis, A.F.G.; van der Poel, W.H.M. First Isolation of Hepatitis E Virus Genotype 4 in Europe through Swine Surveillance in the Netherlands and Belgium. PLoS ONE 2011, 6, e22673. [Google Scholar] [CrossRef]
- Pavio, N.; Meng, X.J.; Renou, C. Zoonotic Hepatitis E: Animal Reservoirs and Emerging Risks. Vet. Res. 2010, 41. [Google Scholar] [CrossRef] [Green Version]
- Boxman, I.L.A.; Jansen, C.C.C.; Hägele, G.; Zwartkruis-Nahuis, A.; Tijsma, A.S.L.; Vennema, H. Monitoring of pork liver and meat products on the Dutch market for the presence of HEV RNA. Int. J. Food Microbiol. 2019, 296, 58–64. [Google Scholar] [CrossRef]
- Yazaki, Y.; Mizuo, H.; Takahashi, M.; Nishizawa, T.; Sasaki, N.; Gotanda, Y.; Okamoto, H. Sporadic Acute or Fulminant Hepatitis E in Hokkaido, Japan, May Be Food-Borne, as Suggested by the Presence of Hepatitis E Virus in Pig Liver as Food. J. Gen. Virol. 2003, 84, 2351–2357. [Google Scholar] [CrossRef]
- Colson, P.; Borentain, P.; Queyriaux, B.; Kaba, M.; Moal, V.; Gallian, P.; Heyries, L.; Raoult, D.; Gerolami, R. Pig Liver Sausage as a Source of Hepatitis E Virus Transmission to Humans. J. Infect. Dis. 2010, 202, 825–834. [Google Scholar] [CrossRef] [Green Version]
- Cooper, K.; Huang, F.F.; Batista, L.; Rayo, C.D.; Bezanilla, J.C.; Toth, T.E.; Meng, X.J. Identification of Genotype 3 Hepatitis E Virus (HEV) in Serum and Fecal Samples from Pigs in Thailand and Mexico, Where Genotype 1 and 2 HEV Strains Are Prevalent in the Respective Human Populations. J. Clin. Microbiol. 2005, 43, 1684–1688. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Berto, A.; Martelli, F.; Grierson, S.; Banks, M. Hepatitis E Virus in Pork Food Chain, United Kingdom, 2009–2010. Emerg. Infect. Dis. 2012, 18, 1358–1360. [Google Scholar] [CrossRef] [PubMed]
- Sooryanarain, H.; Heffron, C.L.; Hill, D.E.; Fredericks, J.; Rosenthal, B.M.; Were, S.R.; Opriessnig, T.; Meng, X.J. Hepatitis E Virus in Pigs from Slaughterhouses, United States, 2017–2019. Emerg. Infect. Dis. 2020, 26, 354–357. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Ahn, J.-M.; Kang, S.-G.; Lee, D.-Y.; Shin, S.J.; Yoo, H.S. Identification of Novel Human Hepatitis E Virus (HEV) Isolates and Determination of the Seroprevalence of HEV in Korea. J. Clin. Microbiol. 2005, 43, 3042–3048. [Google Scholar] [CrossRef] [Green Version]
- Lu, L.; Li, C.; Hagedorn, C.H. Phylogenetic Analysis of Global Hepatitis E Virus Sequences: Genetic Diversity, Subtypes and Zoonosis. Rev. Med. Virol. 2017, 16, 5–36. [Google Scholar] [CrossRef]
- Bouamra, Y.; Gérolami, R.; Arzouni, J.-P.; Grimaud, J.-C.; Lafforgue, P.; Nelli, M.; Tivoli, N.; Ferretti, A.; Motte, A.; Colson, P. Emergence of Autochthonous Infections with Hepatitis E Virus of Genotype 4 in Europe. Intervirology 2014, 57, 43–48. [Google Scholar] [CrossRef]
- Faramawi, M.F.; Johnson, E.; Chen, S.; Pannala, P.R. The Incidence of Hepatitis E Virus Infection in the General Population of the USA. Epidemiol. Infect. 2011, 139, 1145–1150. [Google Scholar] [CrossRef]
- Scobie, L.; Dalton, H.R. Hepatitis E: Source and Route of Infection, Clinical Manifestations and New Developments. J. Viral Hepat. 2013, 20, 1–11. [Google Scholar] [CrossRef]
- Shrestha, A.C.; Faddy, H.M.; Flower, R.L.P.; Seed, C.R.; Keller, A.J. Hepatitis E Virus: Do Locally Acquired Infections in Australia Necessitate Laboratory Testing in Acute Hepatitis Patients with No Overseas Travel History? Pathology 2015, 47, 97–100. [Google Scholar] [CrossRef] [Green Version]
- Krain, L.J.; Nelson, K.E.; Labriquea, A.B. Host Immune Status and Response to Hepatitis E Virus Infection. Clin. Microbiol. Rev. 2014, 27, 139–165. [Google Scholar] [CrossRef] [Green Version]
- Chen, H.Y.; Lu, Y.; Howard, T.; Anderson, D.; Fong, P.Y.; Hu, W.-P.; Chia, C.P.; Guan, M. Comparison of a New Immunochromatographic Test to Enzyme-Linked Immunosorbent Assay for Rapid Detection of Immunoglobulin m Antibodies to Hepatitis e Virus in Human Sera. Clin. Diagn. Lab. Immunol. 2005, 12, 593–598. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Ulanova, T.I.; Obriadina, A.P.; Talekar, G.; Burkov, A.N.; Fields, H.A.; Khudyakov, Y.E. A New Artificial Antigen of the Hepatitis E Virus. J. Immunoass. Immunochem. 2009, 30, 18–39. [Google Scholar] [CrossRef] [PubMed]
- Huang, S.; Zhang, X.; Jiang, H.; Yan, Q.; Ai, X.; Wang, Y.; Cai, J.; Jiang, L.; Wu, T.; Wang, Z.; et al. Profile of Acute Infectious Markers in Sporadic Hepatitis E. PLoS ONE 2010, 5, e13560. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Tian, H.; Fu, X.; Li, W.; Huang, Y.; Sun, J.; Zhou, G.; Zhou, C.; Shen, Q.; Yang, S.; Zhang, W. Genotype 4 Hepatitis E Virus Prevalent in Eastern China Shows Diverse Subtypes. Hepat. Mon. 2015, 15, e25367. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Baylis, S.A.; Sakata, H.; Okada, Y.; Mizusawa, S.; Hanschmann, K.-M.O.; Nübling, C.M.; Matsubayashi, K.; Blümel, J.; Mizusawa, S.; Matsubayashi, K.; et al. World Health Organization International Standard to Harmonize Assays for Detection of Hepatitis E Virus RNA. Emerg. Infect. Dis. 2013, 19, 729–735. [Google Scholar] [CrossRef]
- Lan, X.; Yang, B.; Bao, Y.L.; Xiang, P.Y.; Xue, R.L.; Ji, X.L. Reverse Transcription-Loop-Mediated Isothermal Amplification Assay for Rapid Detection of Hepatitis E Virus. J. Clin. Microbiol. 2009, 47, 2304–2306. [Google Scholar] [CrossRef] [Green Version]
- Li, T.; Takeda, N.; Miyamura, T. Oral administration of hepatitis E virus-like particles induces a systemic and mucosal immune response in mice. Vaccine 2001, 19, 3476–3484. [Google Scholar] [CrossRef]
- Yamamoto, H.; Li, T.C.; Koshimoto, C.; Ito, K.; Kita, M.; Miyashita, N.; Arikawa, J.; Yagami, K.; Asano, M.; Tezuka, H.; et al. Serological evidence for hepatitis e virus infection in laboratory monkeys and pigs in animal facilities in Japan. Exp. Anim. 2008, 57, 367–376. [Google Scholar] [CrossRef] [Green Version]
- Choi, Y.; Zhang, X.; Skinner, B. Analysis of IgG Anti-HEV Antibody Protective Levels During Hepatitis E Virus Reinfection in Experimentally Infected Rhesus Macaques. J. Infect. Dis. 2019, 219, 916–924. [Google Scholar] [CrossRef] [Green Version]
- Sultan Khuroo, M.; Kamili, S.; Yousuf Dar, M.; Moecklii, R.; Jameel, S. Hepatitis E and Long-Term Antibody Status. Lancet 1993, 47, 2304–2306. [Google Scholar]
- Hewitt, P.E.; Ijaz, S.; Brailsford, S.R.; Brett, R.; Dicks, S.; Haywood, B.; Kennedy, I.T.R.; Kitchen, A.; Patel, P.; Poh, J.; et al. Hepatitis E Virus in Blood Components: A Prevalence and Transmission Study in Southeast England. Lancet 2014, 384, 1766–1773. [Google Scholar] [CrossRef] [Green Version]
- Colson, P.; Coze, C.; Gallian, P.; Henry, M.; De Micco, P.; Tamalet, C. Transfusion-Associated Hepatitis E, France. Emerg. Infect. Dis. 2007, 13, 648–649. [Google Scholar] [CrossRef] [PubMed]
- Boxall, E.; Herborn, A.; Kochethu, G.; Pratt, G.; Adams, D.; Ijaz, S.; Teo, C.-G. Transfusion-Transmitted Hepatitis E in a “nonhyperendemic” Country. Transfus. Med. 2006, 16, 79–83. [Google Scholar] [CrossRef] [PubMed]
- Ijaz, S.; Szypulska, R.; Tettmar, K.I.; Kitchen, A.; Tedder, R.S. Detection of Hepatitis E Virus RNA in Plasma Mini-Pools from Blood Donors in England. Vox Sang. 2012, 102, 272. [Google Scholar] [CrossRef] [PubMed]
- Ijaz, S.; Vyse, A.J.; Morgan, D.; Pebody, R.G.; Tedder, R.S.; Brown, D. Indigenous Hepatitis E Virus Infection in England: More Common than It Seems. J. Clin. Virol. 2009, 44, 272–276. [Google Scholar] [CrossRef] [PubMed]
- Mansuy, J.M.; Bendall, R.; Legrand-Abravanel, F.; Sauné, K.; Miédouge, M.; Ellis, V.; Rech, H.; Destruel, F.; Kamar, N.; Dalton, H.R.; et al. Hepatitis E Virus Antibodies in Blood Donors, France. Emerg. Infect. Dis. 2011, 17, 2309–2312. [Google Scholar] [CrossRef] [PubMed]
- Christensen, P.B.; Engle, R.E.; Hjort, C.; Homburg, K.M.; Vach, W.; Georgsen, J.; Purcell, R.H. Time Trend of the Prevalence of Hepatitis E Antibodies among Farmers and Blood Donors: A Potential Zoonosis in Denmark. Clin. Infect. Dis. 2008, 47, 1026–1031. [Google Scholar] [CrossRef]
- Kaufmann, A.; Kenfak-Foguena, A.; André, C.; Canellini, G.; Bürgisser, P.; Moradpour, D.; Darling, K.E.A.; Cavassini, M. Hepatitis E Virus Seroprevalence among Blood Donors in Southwest Switzerland. PLoS ONE 2011, 6, e21150. [Google Scholar] [CrossRef]
- Wenzel, J.J.; Preiss, J.; Schemmerer, M.; Huber, B.; Jilg, W. Test Performance Characteristics of Anti-HEV IgG Assays Strongly Influence Hepatitis E Seroprevalence Estimates. J. Infect. Dis. 2013, 207, 497–500. [Google Scholar] [CrossRef] [Green Version]
- Bendall, R.; Ellis, V.; Ijaz, S.; Ali, R.; Dalton, H. A Comparison of Two Commercially Available Anti-HEV IgG Kits and a Re-Evaluation of Anti-HEV IgG Seroprevalence Data in Developed Countries. J. Med. Virol. 2010, 82, 799–805. [Google Scholar] [CrossRef]
- Park, H.K.; Jeong, S.-H.; Kim, J.-W.; Woo, B.-H.; Lee, D.H.; Kim, H.Y.; Ahn, S. Seroprevalence of Anti-Hepatitis E Virus (HEV) in a Korean Population: Comparison of Two Commercial Anti-HEV Assays. BMC Infect. Dis. 2012, 12, 142. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Mansuy, J.M.; Legrand-Abravanel, F.; Calot, J.P.; Peron, J.M.; Alric, L.; Agudo, S.; Rech, H.; Destruel, F.; Izopet, J. High Prevalence of Anti-Hepatitis E Virus Antibodies in Blood Donors from South West France. J. Med. Virol. 2008, 80, 289–293. [Google Scholar] [CrossRef] [PubMed]
- Labrique, A.B.; Zaman, K.; Hossain, Z.; Saha, P.; Yunus, M.; Hossain, A.; Ticehurst, J.; Nelson, K.E. Population Seroprevalence of Hepatitis E Virus Antibodies in Rural Bangladesh. Am. J. Trop. Med. Hyg. 2009, 81, 875–881. [Google Scholar] [CrossRef] [PubMed]
- Gajjar, M.D.; Bhatnagar, N.M.; Sonani, R.V.; Gupta, S.; Patel, T. Hepatitis E Seroprevalence among Blood Donors: A Pilot Study from Western India. Asian J. Transfus. Sci. 2014, 8, 29–31. [Google Scholar]
- Assarehzadegan, M.A.; Shakerinejad, G.; Amini, A.; Rezaee, S.A.R. Seroprevalence of Hepatitis E Virus in Blood Donors in Khuzestan Province, Southwest Iran. Int. J. Infect. Dis. 2008, 12, 387–390. [Google Scholar] [CrossRef] [Green Version]
- Abdel Hady, S.I.; El-Din, M.S.; El-Din, M.E. A High Hepatitis E Virus (HEV) Seroprevalence among Unpaid Blood Donors and Haemodialysis Patients in Egypt. J. Egypt. Public Health Assoc. 1998, 73, 165–179. [Google Scholar]
- el-Zimaity, D.M.; Hyams, K.C.; Imam, I.Z.; Watts, D.M.; Bassily, S.; Naffea, E.K.; Sultan, Y.; Emara, K.; Burans, J.; Purdy, M.A. Acute Sporadic Hepatitis E in an Egyptian Pediatric Population. Am. J. Trop. Med. Hyg. 1993, 48, 372–376. [Google Scholar] [CrossRef]
- Traoré, K.A.; Rouamba, H.; Nébié, Y.; Sanou, M.; Traoré, A.S.; Barro, N.; Roques, P. Seroprevalence of Fecal-Oral Transmitted Hepatitis A and E Virus Antibodies in Burkina Faso. PLoS ONE 2012, 7, e48125. [Google Scholar] [CrossRef]
- Abdelaal, M.; Zawawi, T.H.; Al Sobhi, E.; Jeje, O.; Gilpin, C.; Kinsara, A.; Osoba, A.; Oni, G.A. Epidemiology of Hepatitis E Virus in Male Blood Donors in Jeddah, Saudi Arabia. Ir. J. Med. Sci. 1998, 167, 94–96. [Google Scholar] [CrossRef]
- Guo, Q.S.; Yan, Q.; Xiong, J.H.; Ge, S.X.; Shih, J.W.K.; Ng, M.H.; Zhang, J.; Xia, N.S. Prevalence of Hepatitis E Virus in Chinese Blood Donors. J. Clin. Microbiol. 2010, 48, 317–318. [Google Scholar] [CrossRef] [Green Version]
- Lorenzo, A.A.; De Guzman, T.S.; Su, G.L.S. Detection of IgM and IgG Antibodies against Hepatitis E Virus in Donated Blood Bags from a National Voluntary Blood Bank in Metro Manila, Philippines. Asian Pacific J. Trop. Dis. 2015, 5, 604–605. [Google Scholar] [CrossRef]
- Gotanda, Y.; Iwata, A.; Ohnuma, H.; Yoshikawa, A.; Mizoguchi, H.; Endo, K.; Takahashi, M.; Okamoto, H. Ongoing Subclinical Infection of Hepatitis E Virus among Blood Donors with an Elevated Alanine Aminotransferase Level in Japan. J. Med. Virol. 2007, 79, 734–742. [Google Scholar] [CrossRef]
- Bortoliero, A.L.; Bonametti, A.M.; Morimoto, H.K.; Matsuo, T.; Reiche, E.M.V. Seroprevalence for Hepatitis E Virus (HEV) Infection among Volunteer Blood Donors of the Regional Blood Bank of Londrina, State of Paraná, Brazil. Rev. Inst. Med. Trop. Sao Paulo 2006, 48, 87–92. [Google Scholar] [CrossRef] [PubMed]
- Schlauder, G.G.; Frider, B.; Sookoian, S.; Castaño, G.C.; Mushahwar, I.K. Identification of 2 Novel Isolates of Hepatitis E Virus in Argentina. J. Infect. Dis. 2000, 182, 294–297. [Google Scholar] [CrossRef] [PubMed]
- Mast, E.E.; Kuramoto, I.K.; Favorov, M.O.; Schoening, V.R.; Burkholder, B.T.; Shapiro, C.N.; Holland, P.V. Prevalence of and Risk Factors for Antibody to Hepatitis E Virus Seroreactivity among Blood Donors in Northern California. J. Infect. Dis. 1997, 176, 34–40. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Zekavat, O.R.; Makarem, A.; Karami, M.Y.; Amanat, A.; Mohandes, M.; Habibagahi, M. Serological Investigation for Hepatitis E Virus Infection in the Patients with Chronic Maintenance Hemodialysis from Southwest of Iran. Asian J. Transfus. Sci. 2013, 7, 21–25. [Google Scholar]
- Taremi, M.; Khoshbaten, M.; Gachkar, L.; EhsaniArdakani, M.; Zali, M. Hepatitis E Virus Infection in Hemodialysis Patients: A Seroepidemiological Survey in Iran. BMC Infect. Dis. 2005, 5, 36. [Google Scholar] [CrossRef] [Green Version]
- Mannucci, P.M.; Gringeri, A.; Santagostino, E.; Romanò, L.; Zanetti, A. Low Risk of Transmission of Hepatitis E Virus by Large-Pool Coagulation Factor Concentrates. Lancet 1994, 343, 597–598. [Google Scholar] [CrossRef]
- Arinsoy, T.; Yilmaz, M.; Derici, U.; Sindel, S.; Tekin, I.; Hasanoglu, E. Prevalence of Hepatitis E Virus Antibody in Hemodialysis Patients. Nephron 1998, 80, 85. [Google Scholar] [CrossRef]
- Stefanidis, I.; Zervou, E.K.; Rizos, C.; Syrganis, C.; Patsidis, E.; Kyriakopoulos, G.; Sdrakas, L.; Tsianas, N.; Rigopoulou, E.I.; Liakopoulos, V.; et al. Hepatitis E Virus Antibodies in Hemodialysis Patients: An Epidemiological Survey in Central Greece. Int. J. Artif. Organ. 2004, 27, 842–847. [Google Scholar] [CrossRef]
- Fabrizi, F.; Lunghi, G.; Bacchini, G.; Corti, M.; Pagano, A.; Locatelli, F. Hepatitis E Virus Infection in Haemodialysis Patients: A Seroepidemiological Survey. Nephrol. Dial. Transpl. 1997, 12, 133–136. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Sylvan, S.P.E.; Jacobson, S.H.; Christenson, B. Prevalence of Antibodies to Hepatitis E Virus among Hemodialysis Patients in Sweden. J. Med. Virol. 1998, 54, 38–43. [Google Scholar] [CrossRef]
- Beladi Mousavi, S.S.; Motemednia, F.; Beladi Mousavi, M. Epidemiology of Hepatitis E Virus Infection in Patients on Chronic Hemodialysis. Jundishapur J. Microbiol. 2014, 7, e6993. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Alavian, S.M.; Ataei, B.; Ebrahimi, A.; Pirhaji, O.; Azad, R.; Olya, B.; Ataei, A.M. Anti-Hepatitis E Antibody in Hemodialysis Patients in Isfahan, Iran: Prevalence and Risk Factors. Hepat. Mon. 2015, 15, e23633. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Psichogiou, M.; Vaindirli, E.; Tzala, E.; Voudiclari, S.; Boletis, J.; Vosnidis, G.; Moutafis, S.; Skoutelis, G.; Hadjiconstantinou, V.; Troonen, H.; et al. Hepatitis E Virus (HEV) Infection in Haemodialysis Patients. The Multicentre Haemodialysis Cohort Study on Viral Hepatitis. Nephrol. Dial. Transpl. 1996, 11, 1093–1095. [Google Scholar] [CrossRef]
- Kamar, N.; Legrand-Abravanel, F.; Izopet, J.; Rostaing, L. Hepatitis E Virus: What Transplant Physicians Should Know. Am. J. Transpl. 2012, 12, 2281–2287. [Google Scholar] [CrossRef]
- Kamar, N.; Izopet, J.; Dalton, H.R. Chronic Hepatitis E Virus Infection and Treatment. J. Clin. Exp. Hepatol. 2013, 3, 134–140. [Google Scholar] [CrossRef] [Green Version]
- Pas, S.D.; de Man, R.A.; Mulders, C.; Balk, A.H.M.M.; van Hal, P.T.W.; Weimar, W.; Koopmans, M.P.G.; Osterhaus, A.D.M.E.; van der Eijk, A.A. Hepatitis E Virus Infection among Solid Organ Transplant Recipients, the Netherlands. Emerg. Infect. Dis. 2012, 18, 869–872. [Google Scholar] [CrossRef]
- Kamar, N.; Izopet, J.; Cintas, P.; Garrouste, C.; Uro-Coste, E.; Cointault, O.; Rostaing, L. Hepatitis E Virus-Induced Neurological Symptoms in a Kidney-Transplant Patient with Chronic Hepatitis. Am. J. Transpl. 2010, 10, 1321–1324. [Google Scholar] [CrossRef]
- Kamar, N.; Garrouste, C.; Haagsma, E.B.; Garrigue, V.; Pischke, S.; Chauvet, C.; Dumortier, J.; Cannesson, A.; Cassuto-Viguier, E.; Thervet, E.; et al. Factors Associated with Chronic Hepatitis in Patients with Hepatitis E Virus Infection Who Have Received Solid Organ Transplants. Gastroenterology 2011, 140, 1481–1489. [Google Scholar] [CrossRef]
- Khameneh, Z.R.; Sepehrvand, N.; Masudi, S. Seroprevalence of Hepatitis E among Iranian Renal Transplant Recipients. Hepat. Mon. 2011, 11, 646–651. [Google Scholar] [CrossRef]
- Naik, A.; Gupta, N.; Goel, D.; Ippagunta, S.K.; Sharma, R.K.; Aggarwal, R. Lack of Evidence of Hepatitis E Virus Infection among Renal Transplant Recipients in a Disease-Endemic Area. J. Viral Hepat. 2013, 20, e138–e140. [Google Scholar] [CrossRef] [PubMed]
- Legrand-Abravanel, F.; Kamar, N.; Sandres-Saune, K.; Lhomme, S.; Mansuy, J.M.; Muscari, F.; Sallusto, F.; Rostaing, L.; Izopet, J. Hepatitis E Virus Infection without Reactivation in Solid-Organ Transplant Recipients, France. Emerg. Infect. Dis. 2011, 17, 30–37. [Google Scholar] [CrossRef] [PubMed]
- Legrand-Abravanel, F.; Kamar, N.; Sandres-Saune, K.; Garrouste, C.; Dubois, M.; Mansuy, J.; Muscari, F.; Sallusto, F.; Rostaing, L.; Izopet, J. Characteristics of Autochthonous Hepatitis E Virus Infection in Solid-Organ Transplant Recipients in France. J. Infect. Dis. 2010, 202, 835–844. [Google Scholar] [CrossRef] [Green Version]
- Breda, F.; Cochicho, J.; Mesquita, J.R.; Bento, A.; Oliveira, R.P.; Louro, E.; Nascimento, M.S.J.; Leitão, J.; Gomes, H.V.; Carvalho, A. First Report of Chronic Hepatitis E in Renal Transplant Recipients in Portugal. J. Infect. Dev. Ctries. 2014, 8, 1639–1642. [Google Scholar] [CrossRef] [Green Version]
- Pischke, S.; Suneetha, P.V.; Baechlein, C.; Barg-Hock, H.; Heim, A.; Kamar, N.; Schlue, J.; Strassburg, C.P.; Lehner, F.; Raupach, R.; et al. Hepatitis E Virus Infection as a Cause of Graft Hepatitis in Liver Transplant Recipients. Liver Transpl. 2010, 16, 74–82. [Google Scholar] [CrossRef]
- Andersson, M.I.; Stead, P.A.; Maponga, T.; van der Plas, H.; Preiser, W. Hepatitis E Virus Infection: An Underdiagnosed Infection in Transplant Patients in Southern Africa? J. Clin. Virol. 2015, 70, 23–25. [Google Scholar] [CrossRef]
- Kamar, N.; Mansuy, J.M.; Cointault, O.; Selves, J.; Abravanel, F.; Danjoux, M.; Otal, P.; Esposito, L.; Durand, D.; Izopet, J.; et al. Hepatitis E Virus-Related Cirrhosis in Kidney-and Kidney-Pancreas- Transplant Recipients. Am. J. Transpl. 2008, 8, 1744–1748. [Google Scholar] [CrossRef]
- Gérolami, R.; Moal, V.; Colson, P. Chronic Hepatitis E with Cirrhosis in a Kidney-Transplant Recipient. N. Engl. J. Med. 2008, 358, 859–860. [Google Scholar] [CrossRef]
- Halleux, D.; Kanaan, N.; Kabamba, B.; Thomas, I.; Hassoun, Z. Hepatitis E Virus: An Underdiagnosed Cause of Chronic Hepatitis in Renal Transplant Recipients. Transpl. Infect. Dis. 2012, 14, 99–102. [Google Scholar] [CrossRef]
- Protzer, U.; Böhm, F.; Longerich, T.; Seebach, J.; Heidary Navid, M.; Friemel, J.; Marques-Maggio, E.; Bawohl, M.; Heikenwalder, M.; Schirmacher, P.; et al. Molecular Detection of Hepatitis E Virus (HEV) in Liver Biopsies after Liver Transplantation. Mod. Pathol. 2015, 28, 523–532. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Koning, L.; Charlton, M.R.; Pas, S.D.; Heimbach, J.K.; Osterhaus, A.D.M.E.; Watt, K.D.; Janssen, H.L.A.; de Knegt, R.J.; van der Eijk, A.A. Prevalence and Clinical Consequences of Hepatitis E in Patients Who Underwent Liver Transplantation for Chronic Hepatitis C in the United States. BMC Infect. Dis. 2015, 15, 371. [Google Scholar] [CrossRef] [PubMed]
- Kamar, N.; Abravanel, F.; Selves, J.; Garrouste, C.; Esposito, L.; Lavayssière, L.; Cointault, O.; Ribes, D.; Cardeau, I.; Nogier, M.B.; et al. Influence of Immunosuppressive Therapy on the Natural History of Genotype 3 Hepatitis-E Virus Infection after Organ Transplantation. Transplantation 2010, 89, 353–360. [Google Scholar] [CrossRef] [PubMed]
- Banks, M.; Bendall, R.; Grierson, S.; Heath, G.; Mitchell, J.; Dalton, H. Human and Porcine Hepatitis E Virus Strains, United Kingdom. Emerg. Infect. Dis. 2004, 10, 953–955. [Google Scholar] [CrossRef] [PubMed]
- Yugo, D.M.; Meng, X.J. Hepatitis E Virus: Foodborne, Waterborne and Zoonotic Transmission. Int. J. Environ. Res. Public Health 2013, 10, 4507–4533. [Google Scholar] [CrossRef] [PubMed]
- Tan, H.-H.; Leong, H.-N.; Tan, B.-H.; Oon, L.L.-E.; Lim, K.-H.; Chang, J.P.-E.; Tan, C.-K. Chronic Hepatitis e Infection Resulting in Graft Failure in a Liver Transplant Tourist. Case Rep. Transpl. 2011, 2011, 654792. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Kamar, N.; Rostaing, L.; Abravanel, F.; Garrouste, C.; Esposito, L.; Cardeau-Desangles, I.; Mansuy, J.M.; Selves, J.; Peron, J.M.; Otal, P.; et al. Pegylated Interferon-α for Treating Chronic Hepatitis E Virus Infection after Liver Transplantation. Clin. Infect. Dis. 2010, 50, e30–e33. [Google Scholar] [CrossRef] [Green Version]
- Riezebos-Brilman, A.; Puchhammer-Stöckl, E.; Van Der Weide, H.Y.; Haagsma, E.B.; Jaksch, P.; Bejvl, I.; Niesters, H.G.; Verschuuren, E.A.M. Chronic Hepatitis e Infection in Lung Transplant Recipients. J. Heart. Lung Transpl. 2013, 32, 341–346. [Google Scholar] [CrossRef]
- Pischke, S.; Stiefel, P.; Franz, B.; Bremer, B.; Suneetha, P.V.; Heim, A.; Ganzenmueller, T.; Schlue, J.; Horn-Wichmann, R.; Raupach, R.; et al. Chronic Hepatitis e in Heart Transplant Recipients. Am. J. Transpl. 2012, 12, 3128–3133. [Google Scholar] [CrossRef]
- Kamar, N.; Izopet, J.; Tripon, S.; Bismuth, M.; Hillaire, S.; Dumortier, J.; Radenne, S.; Coilly, A.; Garrigue, V.; D’Alteroche, L.; et al. Ribavirin for Chronic Hepatitis E Virus Infection in Transplant Recipients. N. Engl. J. Med. 2014, 370, 1111–1120. [Google Scholar] [CrossRef] [Green Version]
- Waldenström, J.; Castedal, M.; Konar, J.; Karason, K.; Lagging, M.; Norder, H. Chronic Hepatitis E Infection with an Emerging Virus Strain in a Heart Transplant Recipient Successfully Treated with Ribavirin: A Case Report. J. Med. Case Rep. 2015, 9, 180. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Teshale, E.H.; Howard, C.M.; Grytdal, S.P.; Handzel, T.R.; Barry, V.; Kamili, S.; Drobeniuc, J.; Okware, S.; Downing, R.; Tappero, J.W.; et al. Hepatitis E Epidemic, Uganda. Emerg. Infect. Dis. 2010, 16, 126–129. [Google Scholar] [CrossRef] [PubMed]
- Aggarwal, R.; Naik, S.R. Hepatitis E: Intrafamilial Transmission versus Waterborne Spread. J. Hepatol. 1994, 21, 718–723. [Google Scholar] [CrossRef]
- Howard, C.M.; Handzel, T.; Hill, V.R.; Grytdal, S.P.; Blanton, C.; Kamili, S.; Drobeniuc, J.; Hu, D.; Teshale, E. Novel Risk Factors Associated with Hepatitis E Virus Infection in a Large Outbreak in Northern Uganda: Results from a Case-Control Study and Environmental Analysis. Am. J. Trop. Med. Hyg. 2010, 83, 1170–1173. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Choi, I.-S.; Kwon, H.-J.; Shin, N.-R.; Yoo, H.S. Identification of Swine Hepatitis E Virus (HEV) and Prevalence of Anti-HEV Antibodies in Swine and Human Populations in Korea. J. Clin. Microbiol. 2003, 41, 3602–3608. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Wichmann, O.; Schimanski, S.; Koch, J.; Kohler, M.; Rothe, C.; Plentz, A.; Jilg, W.; Stark, K. Phylogenetic and Case-Control Study on Hepatitis E Virus Infection in Germany. J. Infect. Dis. 2008, 198, 1732–1741. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Dalton, H.R.; Bendall, R.P.; Rashid, M.; Ellis, V.; Ali, R.; Ramnarace, R.; Stableforth, W.; Headdon, W.; Abbott, R.; McLaughlin, C.; et al. Host Risk Factors and Autochthonous Hepatitis e Infection. Eur. J. Gastroenterol. Hepatol. 2011, 23, 1200–1205. [Google Scholar] [CrossRef]
- Huang, F.; Wang, J.; Yang, C.; Long, F.; Li, Y.; Li, L.; Jing, S.; Wang, H. Chinese Pregnant Women in Their Third Trimester Are More Susceptible to HEV Infection. Braz. J. Infect. Dis. 2015, 19, 672–674. [Google Scholar] [CrossRef] [Green Version]
- Navaneethan, U.; Al Mohajer, M.; Shata, M.T. Hepatitis E and Pregnancy: Understanding the Pathogenesis. Liver Int. 2008, 28, 1190–1199. [Google Scholar] [CrossRef] [Green Version]
- Safary, A. Perspectives of Vaccination against Hepatitis E. Intervirology 2001, 44, 162–166. [Google Scholar] [CrossRef]
- Zhu, F.-C.; Zhang, J.; Zhang, X.-F.; Zhou, C.; Wang, Z.-Z.; Huang, S.-J.; Wang, H.; Yang, C.-L.; Jiang, H.-M.; Cai, J.-P.; et al. Efficacy and Safety of a Recombinant Hepatitis E Vaccine in Healthy Adults: A Large-Scale, Randomised, Double-Blind Placebo-Controlled, Phase 3 Trial. Lancet 2010, 376, 895–902. [Google Scholar] [CrossRef]
© 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Janahi, E.M.; Parkar, S.F.D.; Mustafa, S.; Eisa, Z.M. Implications of Hepatitis E Virus in Blood Transfusions, Hemodialysis, and Solid Organ Transplants. Medicina 2020, 56, 206. https://doi.org/10.3390/medicina56050206
Janahi EM, Parkar SFD, Mustafa S, Eisa ZM. Implications of Hepatitis E Virus in Blood Transfusions, Hemodialysis, and Solid Organ Transplants. Medicina. 2020; 56(5):206. https://doi.org/10.3390/medicina56050206
Chicago/Turabian StyleJanahi, Essam M., Saba F. D. Parkar, Sakina Mustafa, and Zaki M. Eisa. 2020. "Implications of Hepatitis E Virus in Blood Transfusions, Hemodialysis, and Solid Organ Transplants" Medicina 56, no. 5: 206. https://doi.org/10.3390/medicina56050206